ParaPRO Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 30
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 1

ParaPRO General Information

Description

Developer of medicines for the treatment of head lice. The company operates as a specialty pharmaceutical created to acquire, develop and commercialize proprietary products.

Contact Information

Website
www.parapro.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 11550 North Meridian Street
  • Suite 290
  • Carmel, IN 46032
  • United States
+1 (317) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ParaPRO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 10-Apr-2020 Completed
1. Grant 21-Sep-2007 00.00 Completed Startup
To view ParaPRO’s complete valuation and funding history, request access »

ParaPRO Executive Team (5)

Name Title Board Seat Contact Info
William Culpepper III President
Michael Puckett Chief Financial Officer
David Bedich Vice President of Sales, Executive Director and Director of Trade Commercialization & Reimbursement
William Culpepper Chief Executive Officer
You’re viewing 4 of 5 executive team members. Get the full list »

ParaPRO Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ParaPRO Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate Ventures Venture Capital Minority 000 0000 000000 0
To view ParaPRO’s complete investors history, request access »